'I have said repeatedly...while the PBAC starts with a P it does not comment on policy'

It would have been more appropriate to ask for the committee's view on how a reduction in the base-case discount rate would contribute to accelerating funded access to new medicines and vaccines under its current statutory decision-making framework. …